Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cryptococcal Meningitis in HIV-Infected Patients.

Literature DB >> 11095877

Cryptococcal Meningitis in HIV-Infected Patients.

Abstract

Cryptococcosis is a fungal infection that is potentially deadly for and common among AIDS patients, in the United States and worldwide. Subacute meningitis and meningoencephalitis are typical, clinically. This article will review relevant aspects of cryptococcal meningitis in AIDS, focusing on the most recent information pertaining to pathogenesis, epidemiology, clinical syndromes, and treatment of this devastating disease.

Entities: Disease Species

Year: 2000 PMID： 11095877 DOI： 10.1007/s11908-000-0015-y

Source DB: PubMed Journal: Curr Infect Dis Rep ISSN： 1523-3847 Impact factor: 3.725

45 in total

1. Mediastinal lymphadenitis due to cryptococcal infection in HIV-positive patients on highly active antiretroviral therapy.

Authors: M Lanzafame; M Trevenzoli; G Carretta; L Lazzarini; S Vento; E Concia
Journal: Chest Date: 1999-09 Impact factor: 9.410

2. Itraconazole prophylaxis for fungal infections in patients with advanced human immunodeficiency virus infection: randomized, placebo-controlled, double-blind study. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors: D S McKinsey; L J Wheat; G A Cloud; M Pierce; J R Black; D M Bamberger; M Goldman; C J Thomas; H M Gutsch; B Moskovitz; W E Dismukes; C A Kauffman
Journal: Clin Infect Dis Date: 1999-05 Impact factor: 9.079

3. Changes in AIDS-defining illnesses in a London Clinic, 1987-1998.

Authors: A Mocroft; C A Sabin; M Youle; S Madge; M Tyrer; H Devereux; J Deayton; A Dykhoff; M C Lipman; A N Phillips; M A Johnson
Journal: J Acquir Immune Defic Syndr Date: 1999-08-15 Impact factor: 3.731

4. Comparison of amphotericin B with fluconazole in the treatment of acute AIDS-associated cryptococcal meningitis. The NIAID Mycoses Study Group and the AIDS Clinical Trials Group.

Authors: M S Saag; W G Powderly; G A Cloud; P Robinson; M H Grieco; P K Sharkey; S E Thompson; A M Sugar; C U Tuazon; J F Fisher
Journal: N Engl J Med Date: 1992-01-09 Impact factor: 91.245

5. Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of AIDS-associated cryptococcal meningitis.

Authors: A C Leenders; P Reiss; P Portegies; K Clezy; W C Hop; J Hoy; J C Borleffs; T Allworth; R H Kauffmann; P Jones; F P Kroon; H A Verbrugh; S de Marie
Journal: AIDS Date: 1997-10 Impact factor: 4.177

6. Serotypes of Cryptococcus neoformans in patients with AIDS.

Authors: M G Rinaldi; D J Drutz; A Howell; M A Sande; C B Wofsy; W K Hadley
Journal: J Infect Dis Date: 1986-03 Impact factor: 5.226

7. Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis.

Authors: E Mylonakis; N A Merriman; J D Rich; T P Flanigan; B C Walters; K T Tashima; M D Mileno; C M van der Horst
Journal: Diagn Microbiol Infect Dis Date: 1999-06 Impact factor: 2.803

8. Effects of antifungal agents and gamma interferon on macrophage cytotoxicity for fungi and tumor cells.

Authors: J R Perfect; D L Granger; D T Durack
Journal: J Infect Dis Date: 1987-08 Impact factor: 5.226

9. A comparison of itraconazole versus fluconazole as maintenance therapy for AIDS-associated cryptococcal meningitis. National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Authors: M S Saag; G A Cloud; J R Graybill; J D Sobel; C U Tuazon; P C Johnson; W J Fessel; B L Moskovitz; B Wiesinger; D Cosmatos; L Riser; C Thomas; R Hafner; W E Dismukes
Journal: Clin Infect Dis Date: 1999-02 Impact factor: 9.079

10. Fluconazole combined with flucytosine for treatment of cryptococcal meningitis in patients with AIDS.

Authors: R A Larsen; S A Bozzette; B E Jones; D Haghighat; M A Leal; D Forthal; M Bauer; J G Tilles; J A McCutchan; J M Leedom
Journal: Clin Infect Dis Date: 1994-10 Impact factor: 9.079

8 in total

1. Voriconazole, combined with amphotericin B, in the treatment for pulmonary cryptococcosis caused by C. neoformans (serotype A) in mice with severe combined immunodeficiency (SCID).

Authors: Eriques Gonçalves Silva; Claudete Rodrigues Paula; Francisco de Assis Baroni; Walderez Gambale
Journal: Mycopathologia Date: 2011-11-10 Impact factor: 2.574

2. Combination efficacy of voriconazole and amphotericin B in the experimental disease in immunodeficient mice caused by fluconazole-resistant Cryptococcus neoformans.

Authors: Eriques Gonçalves Silva; Claudete Rodrigues Paula; Amanda Latercia Tranches Dias; Marilene Rodrigues Chang; Luciana da Silva Ruiz; Valderez Gambale; Renato Araujo Prates; Martha Simões Ribeiro
Journal: Mycopathologia Date: 2010-10-24 Impact factor: 2.574

3. Cryptococcus neoformans senses CO2 through the carbonic anhydrase Can2 and the adenylyl cyclase Cac1.

Authors: Estelle Geweiss Mogensen; Guilhem Janbon; James Chaloupka; Clemens Steegborn; Man Shun Fu; Frédérique Moyrand; Torsten Klengel; David S Pearson; Michael A Geeves; Jochen Buck; Lonny R Levin; Fritz A Mühlschlegel
Journal: Eukaryot Cell Date: 2006-01